Related Experiment Video
Updated: Aug 6, 2026
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Laryngeal electromyographic findings in Charcot-Marie-Tooth disease type II
T G Dray1, L R Robinson, A D Hillel
1Department of Otolaryngology-Head and Neck Surgery, University of Washington Medical Center, Seattle 98195, USA.
Archives of Neurology
|July 15, 1999
Summary
Charcot-Marie-Tooth disease type II C, a form of hereditary neuropathy, involves diaphragm and vocal cord weakness. Laryngeal electromyography shows potential for diagnosing this subtype of Charcot-Marie-Tooth disease.
Area of Science:
- Neurology
- Genetics
- Clinical Electrophysiology
Background:
- Charcot-Marie-Tooth disease is a heterogeneous hereditary neuropathy characterized by progressive limb muscle atrophy.
- It presents diverse clinical and genetic subtypes, necessitating precise diagnostic approaches.
- Charcot-Marie-Tooth disease type II C is specifically associated with axonal neuropathy, diaphragm weakness, and vocal cord paralysis.
Observation:
- A patient diagnosed with Charcot-Marie-Tooth disease type II C presented with vocal cord paralysis.
- Laryngeal electromyography was employed to investigate the neuromuscular function in the affected laryngeal muscles.
Findings:
- Laryngeal electromyography provided valuable insights into the neuromuscular deficits in the patient.
- The study demonstrated the utility of laryngeal electromyography in characterizing the specific manifestations of Charcot-Marie-Tooth disease type II C.
Implications:
- Laryngeal electromyography may serve as a crucial diagnostic tool for Charcot-Marie-Tooth disease type II C.
- This technique can aid in understanding the pathophysiology and progression of laryngeal involvement in hereditary neuropathies.
- Further research utilizing laryngeal electromyography could refine diagnostic criteria and therapeutic strategies for Charcot-Marie-Tooth disease subtypes.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...